|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of testis, unsp descended or undescended
ICD-10 (CM) Code and Descriptor
|
C62.91 |
Malignant neoplasm of right testis, unspecified whether descended or undescended
Diagnosis Valid for Male Patient Only
|
C6291 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 56.65%
|
25.65%
|
7.82%
|
2.81%
|
1.87%
|
1.14%
|
0.67%
|
1.07%
|
1.14%
|
0.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C62.91*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
358
|
359
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
322
|
325
|
|
80053
|
COMPREHEN METABOLIC PANEL |
319
|
319
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
316
|
316
|
|
82105
|
ALPHA-FETOPROTEIN SERUM |
315
|
315
|
|
84702
|
CHORIONIC GONADOTROPIN TEST |
276
|
279
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
265
|
265
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
152
|
16,314
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
150
|
150
|
|
71260
|
CT THORAX DX C+ |
101
|
101
|
|
J3010
|
FENTANYL CITRATE INJECTION |
90
|
145
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
79
|
2,038
|
|
J2405
|
ONDANSETRON HCL INJECTION |
78
|
385
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
73
|
290
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
68
|
516
|
|
54530
|
REMOVAL OF TESTIS |
66
|
66
|
|
88309
|
TISSUE EXAM BY PATHOLOGIST |
63
|
63
|
|
83735
|
ASSAY OF MAGNESIUM |
61
|
61
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
58
|
233
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
56
|
56
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C62.91 related to the following DRG Codes:
715-716
722-724
|
